PDS >> Efficacy Models >> Oncology

Oncology Drug Discovery Services

Pharmacology Discovery Services has over 30 years of experience in conducting in vivo pharmacology services.  We have a portfolio of both xenograft and syngeneic models that our clients may use to assess the in vivo efficacy of their Oncology drug discovery test agents.  We also provide pharmacokinetic (PK) and safety/tolerability models to enable the evaluation of test agents prior to conducting efficacy studies.  All study protocols are written and reviewed by our team of highly experienced Oncology Technical and Study Directors, our team may also develop custom in vivo models to meet the specific needs of your Oncology drug discovery program.

Through our Partner Lab, Eurofins Pharma Discovery Services, our clients also have access to an extensive portfolio of in vitro products and services that can add value to your Oncology drug discovery program, highlighted by the OncoPanel™ Cell-Based Profiling Service.  Other in vitro products and services that can add value throughout drug discovery include: in vitro pharmacology, cell-based phenotypic assays, ADME-Tox, and custom proteins & assay development services. 

With the breadth of both in vivo and in vitro services from Pharmacology Discovery Services and our Partner Lab, Eurofins Pharma Discovery Services, our clients have access to the assays, and expertise, that will enhance decision making throughout the drug discovery process.

In vivo
In vitro